2,193 results on '"Lee, Sung-Gyu"'
Search Results
2. Safety of right liver donation after improving steatosis through weight loss in living donors: a retrospective study
3. Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients
4. Organic molecules as origin of visible-range single photon emission from hexagonal boron nitride and mica
5. Outcomes of 6000 living donor liver transplantation procedures: a pioneering experience at ASAN Medical Center
6. Catalytic enhancements in cytochrome P450 2C19 by cytochrome b5
7. A novel scoring system to predict short-term mortality after living donor liver transplantation for acute liver failure
8. Contrast-Enhanced T1-Weighted Magnetic Resonance Cholangiography Using Gadoxetate Disodium in Potential Living Liver Donors: Qualitative and Quantitative Improvement with 3-hour Delayed Imaging
9. Non-oxidized bare copper nanoparticles with surface excess electrons in air.
10. Reconstruction of Hepatic Vein and Portal Vein
11. Aborted living-donor liver transplantation in the real-world setting, lessons from 13 937 cases of Vanguard Multi-center Study of International Living Donor Liver Transplantation Group
12. Achieving 400 Living Donor Liver Transplantations Annually During the COVID-19 Pandemic: A Single-Center Experience
13. Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy
14. Reduced Ceramides Are Associated with Acute Rejection in Liver Transplant Patients and Skin Graft and Hepatocyte Transplant Mice, Reducing Tolerogenic Dendritic Cells
15. Observation of an exceptional point in a non-Hermitian metasurface
16. Short-Term Results of Plug-Assisted Retrograde Transvenous Obliteration for Portal Steal from Complicated Portosystemic Shunts in Living-Donor Liver Transplantation
17. Hydroxylation and lyase reactions of steroids catalyzed by mouse cytochrome P450 17A1 (Cyp17a1)
18. A Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Tacrolimus and Corticosteroids in Combination With or Without Mycophenolate Mofetil in Liver Transplantation Recipients Infected With Hepatitis B Virus
19. CT-based visual grading system for assessment of hepatic steatosis: diagnostic performance and interobserver agreement
20. Therapeutic strategies for liver diseases based on redox control systems
21. Analysis of outcomes and renal recovery after adult living-donor liver transplantation among recipients with hepatorenal syndrome
22. Operative and long-term oncologic outcomes of laparoscopic versus open major liver resection in patients with a high body mass index (> 25 kg/m2): a propensity score matching analysis
23. Morbidity analysis of left hepatic trisectionectomy for hepatobiliary disease and live donor
24. ASO Visual Abstract: Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Hepatectomy
25. Selective photocatalytic conversion of benzyl alcohol to benzaldehyde or deoxybenzoin over ion-exchanged CdS
26. Visceral Fat Area Is an Independent Risk Factor for Overweight or Obese Nonalcoholic Fatty Liver Disease in Potential Living Liver Donors
27. Nano-biomarker-Based Surface-Enhanced Raman Spectroscopy for Selective Diagnosis of Gallbladder and Liver Injury
28. Efficacy and Safety Evaluation After Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Recipients: A Phase 4, Open-Label, Single-Center Study
29. Feasibility of modified endarterectomized aortic allograft for middle hepatic vein reconstruction in living donor liver transplantation: A retrospective cohort study
30. Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation
31. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
32. Clinical Characteristics and Risk Factors of Early-Onset Tuberculosis After Liver Transplantation
33. Microsurgical Hepatic Artery Reconstruction in Deceased Donor Liver Transplantation for Reduced Arterial Complications
34. Renal Recovery After Liver Transplantation Alone in Patients With Liver Cirrhosis and Severe Chronic Kidney Disease With Normal Kidney Size
35. Characteristics and Prognosis of Colorectal Cancer after Liver or Kidney Transplantation
36. Liver Imaging Reporting and Data System Category on Magnetic Resonance Imaging Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation Within the Milan Criteria: A Multicenter Study
37. Surgical Outcomes of Spontaneously Ruptured Hepatocellular Carcinoma
38. Application of Proximal Splenic Vein Embolization to Interrupt Complicated Large Splenorenal Shunts in Adult Living Donor Liver Transplantation
39. Preoperative prediction score of hepatocellular carcinoma recurrence in living donor liver transplantation: Validation of SNAPP score developed at Asan Medical Center
40. Single-Center Experience of Living Donor Liver Transplantation for Patients With Secondary Biliary Cirrhosis
41. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes
42. Over 500 Liver Transplants Including More Than 400 Living-Donor Liver Transplants in 2019 at Asan Medical Center
43. Importance of Imaging Plane of Gadoxetic Acid--Enhanced Magnetic Resonance Cholangiography for Bile Duct Anatomy in Healthy Liver Donors
44. Life-Threatening Portal Flow Steal Reappearing Under Increased Intrahepatic Vascular Resistance After Living Donor Liver Transplantation
45. Change in hepatic volume profile in potential live liver donors after lifestyle modification for reduction of hepatic steatosis
46. Antioxidative and Anti-Atopic Dermatitis Effects of Peptides Derived from Hydrolyzed Sebastes schlegelii Tail By-Products.
47. Biliary Complications After Single- and Dual-Graft Living-Donor Liver Transplantation Using a Right Posterior Section Graft of Donor with a Type III Portal Vein Variation
48. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma
49. Liver Steatosis in Brain-Dead Donors: Progression Pattern and Affecting Factors
50. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.